F-group (family)
2006.1.6.1 VWA
Ligands and drugs
1,105
Member domains
350
with ligand contacts (≤ 4 Å)
31.7% of members
330
with DrugDomain annotations
29.9% of members
189
with a DrugBank compound
17.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2006.1.6.1 belongs to X-group 2006 HAD domain-like, which binds 9.7 ligand superclasses per 20 proteins, broader than 91% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 31 |
| DB01593 | — | — | 5 |
| DB14487 | — | — | 5 |
| DB00227 | 803 | Lovastatin | 4 |
| DB02177 | L08 | 1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine | 4 |
| DB14533 | — | — | 4 |
| DB00753 | ICF | Isoflurane | 2 |
| DB03932 | AAY | LFA703 | 2 |
| DB04724 | LA1 | (S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide | 2 |
| DB07486 | BQM | 3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline | 2 |
| DB00230 | — | — | 1 |
| DB00270 | — | — | 1 |
| DB00308 | — | — | 1 |
| DB00401 | — | — | 1 |
| DB00622 | — | — | 1 |
| DB00641 | — | — | 1 |
| DB00974 | EDT | Edetic acid | 1 |
| DB00996 | — | Gabapentin | 1 |
| DB01023 | — | — | 1 |
| DB01054 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 159 |
| CL | CHLORIDE ION | 85 |
| NAmetal | SODIUM ION | 77 |
| CAmetal | CALCIUM ION | 36 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 34 |
| MNmetal | MANGANESE (II) ION | 23 |
| ZNmetal | ZINC ION | 12 |
| CDmetal | CADMIUM ION | 10 |
| NImetal | NICKEL (II) ION | 9 |
| COmetal | COBALT (II) ION | 8 |
| BAmetal | BARIUM ION | 6 |
| CRmetal | CHROMIUM ION | 6 |
| PRmetal | PRASEODYMIUM ION | 6 |
| SRmetal | STRONTIUM ION | 6 |
| Y1metal | YTTRIUM ION | 6 |
| 803 | LOVASTATIN | 4 |
| L08 | 1-ACETYL-4-(4-{4-[(2-ETHOXYPHENYL)THIO]-3-NITROPHENYL}PYRIDIN-2-YL)PIPERAZINE | 4 |
| BJZ | 6-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl]pyridine-3-carboxylic acid | 3 |
| AAY | 8-[2-((2S)-4-HYDROXY-1-{[5-(HYDROXYMETHYL)-6-METHOXY-2-NAPHTHYL]METHYL}-6-OXOPIPERIDIN-2-YL)ETHYL]-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL 2-METHYLBUTANOATE | 2 |
| AB8 | (1S,3R,8AS)-8-(2-{(4S,6S)-3-(4-HYDROXY-3-METHOXYBENZYL)-4-[2-(METHYLAMINO)-2-OXOETHYL]-2-OXO-1,3-OXAZINAN-6-YL}ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL (2R)-2-METHYLBUTANOATE | 2 |